25-Hydroxy Vitamin D Levels in Hemodialysis-Requiring End-Stage Renal Disease Patients
✍ Scribed by Guillermo Javier Rosa Diez; Juliana Fassi; Soledad Crucelequi; Hector Rivera Nuñez; Matias Trillini; Aida Furci; Salomón Algranati; Luisa Plantalech
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2008
- Tongue
- English
- Weight
- 107 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0090-2934
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Ischemia‐Modified albumin (IMA) has been used as an early marker in the evaluation of the patients with acute coronary syndrome. We aimed to evaluate IMA in end‐stage renal disease (ESRD) patients on hemodialysis and the effect of albumin methods on albumin‐adjusted IMA levels. A total
## Abstract In end‐stage renal disease patients treated by hemodialysis with HBeAg‐negative chronic hepatitis B virus (HBV) infection, the evaluation of the presence of viral replication is essential in the assessment for renal transplantation. Data on HBV viral load, prevalence of precore mutation
## Abstract Low pretreatment vitamin D status has been associated with worsened disease outcomes in patients with cancer at various sites. Its prognostic significance in head and neck cancer (HNC) patients has not been studied. Patients with HNC who participated in a randomized trial were evaluated
## Abstract ## Background There are emerging data that simultaneous pancreas–kidney transplant (SPK) prolongs life compared with kidney transplant alone (KTA) in type 1 diabetics with end-stage renal disease. This study was a retrospective comparison of SPK with KTA in patients with type 1 diabete